BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/13/2026 8:07:32 AM | Browse: 6 | Download: 4
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Editorial |
| Article Title |
Ongoing need for biomarkers predicting activity of inflammatory bowel disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
M Jesús Fernández-Aceñero |
| Funding Agency and Grant Number |
|
| Corresponding Author |
M Jesús Fernández-Aceñero, Full Professor, Department of Surgical Pathology, Health Research Institute of the Hospital Clínico San Carlos, Hospital Clínico San Carlos, Professor Martín Lagos Street, Madrid 28040, Spain. mgg10167@gmail.com |
| Key Words |
Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis; Biomarkers; Relapse; Calprotectin; Oncostatin M; Micro-RNA; Artificial intelligence; Therapeutic drug monitoring |
| Core Tip |
Inflammatory bowel disease is a severe relapsing inflammatory disease and early detection and treatment can help improve patients’ outcome. Although endoscopic and histopathological scores remain as the most reliable marker for disease relapses, they are invasive and there is a clear need to find biomarkers that allow a non-invasive and practical approach to disease diagnosis and treatment. Fecal calprotectin has emerged as the most useful biomarker, but there is still a great need to increase accuracy. Novel technologies, including the different omics, and several emerging biomarkers promise to improve the field of inflammatory bowel disease diagnosis and management in the near future, also fueled by the development of artificial intelligence-based strategies. |
| Citation |
Fernández-Aceñero MJ. Ongoing need for biomarkers predicting activity of inflammatory bowel disease. World J Gastroenterol 2026; In press
|
| PDF |
117754-in-press.pdf
|
 |
Received |
|
2025-12-15 05:09 |
 |
Peer-Review Started |
|
2025-12-15 05:09 |
 |
First Decision by Editorial Office Director |
|
2026-01-28 09:21 |
 |
Return for Revision |
|
2026-01-28 09:21 |
 |
Revised |
|
2026-06-24 08:47 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-07-13 02:36 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-07-13 08:07 |
 |
Articles in Press |
|
2026-07-13 08:07 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.